Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul 2:9:158.
doi: 10.1186/1742-2094-9-158.

Elevated serum levels of interleukin-17A in children with autism

Laila Yousef Al-Ayadhi  1 , Gehan Ahmed Mostafa
Affiliations

Elevated serum levels of interleukin-17A in children with autism

Laila Yousef Al-Ayadhi et al. J Neuroinflammation. .

Abstract

Background: The T-helper (Th)1/Th2 dichotomy dominated the field of immune regulation until interleukin (IL)-17-expressing T cells (Th17) were proposed to be a third lineage of helper T cells, the key players in the pathogenesis of autoimmune disorders. Autoimmunity to brain tissue may play a pathogenic role in autism. IL-17A is a pro-inflammatory cytokine that has been shown to play an important role in various autoimmune neuroinflammatory diseases. The aim of this study was to measure serum levels of IL-17A in relation to the degree of the severity of autism.

Methods: Serum IL-17A levels were measured by ELISA in 45 children with autism and 40 matched healthy controls.

Results: Children with autism had significantly higher serum IL-17A levels than healthy controls (P <0.001), with increased serum levels of IL-17A found in 48.9% of the autism group. Patients with severe autism had significantly higher serum IL-17A levels than those with mild to moderate autism (P=0.01), and raised serum IL-17A levels were significantly more common in children with severe autism (67.9%) than in those with mild to moderate autism (17.6%), P=0.001.

Conclusions: Serum IL-17A levels were raised in the group with autism, and the levels correlated significantly with the severity of autism. This is the first study to measure levels of IL-17A in relation to the severity of autism, to our knowledge. Further research, with a larger subject population, is warranted to determine whether the increase of serum IL-17A levels plasma has a pathogenic role in autism, and whether anti- IL-17A therapy could be useful.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Serum levels of IL-17A in autistic patients and healthy children. Median value for each group is shown by a horizontal bar.
Figure 2
Figure 2
Serum levels of IL-17A in relation to the degree of the severity of autism. Median value for each group is shown by a horizontal bar.
See this image and copyright information in PMC

References

    1. Dong C. Genetic controls of Th17 cell differentiation and plasticity. Exp Mol Med. 2011;43(1):1–6. doi: 10.3858/emm.2011.43.1.007. - DOI - PMC - PubMed
    1. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM. et al.Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123–1132. doi: 10.1038/ni1254. - DOI - PubMed
    1. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH. et al.A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6(11):1133–1141. doi: 10.1038/ni1261. - DOI - PMC - PubMed
    1. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity. 2006;24:677–688. doi: 10.1016/j.immuni.2006.06.002. - DOI - PubMed
    1. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M. et al.Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235–238. doi: 10.1038/nature04753. - DOI - PubMed

Publication types

LinkOut - more resources